Skip to main content
. 2021 Feb 16;11(2):e040212. doi: 10.1136/bmjopen-2020-040212

Figure 2.

Figure 2

Forest plot comparing all-cause mortality between direct oral anticoagulant (DOAC) and standard therapy (warfarin, low molecular weight heparin or unfractionated heparin) for cerebral venous thrombosis.